Flector Tissugel 10 plei
Flector Tissugel 10 plei
Flector Tissugel 10 plei
Flector Tissugel 10 plei

Flector Tissugel 10 plei

THERABEL PHARMA
1530922
Rupture de stock
€25.90
Tax included
Therapeutic Indications:

 

Flector Tissugel 10 plei

.

Therapeutic Indications:

Local symptomatic treatment - post-traumatic inflammation of the tendons, ligaments, muscles and joints - abarticulair localized forms of rheumatism, such as tenosynovitis, shoulder-hand syndrome, bursitis, - localized, rheumatic, inflammatory diseases, including inflammatory arthritis and to run against periarticulaire disorders.

Qualitative and quantitative composition:


The active ingredient is diclofenac. It is present in the form of the salt of diclofenac and 2-hydroxyethyl 1-pyrrolidine (diclofenacepolamine = = DHEP). Each gauze diclofenacepolamine contains 180 mg, corresponding to 1% diclofenac sodium.
For excipients, see List of excipients.

Pharmaceutical form:


reflector Tissugel 1% impregnated gauze related: rectangular connection of gauze 14 x 10 cm.

Posology and method of administration:


Adults and adolescents over 15 years.

twice a day, morning and evening, an adhesive, impregnated gauze to affected zone application.
If possible avoid multiple zones simultaneously treat.
Treatment duration should not exceed 14 days.
Tissugel reflector may be used together with another oral, non-steroidal anti-inflammatory drug based on diclofenac.
Elderly patients.

Tissugel reflector must be used with caution in the elderly because of the higher risk of side effects (see section 'Special warnings and precautions for use').
Children younger than 15 years.

Since the use of reflector Tissugel in children younger than 15 ; years was not specifically studied, was used in this group is not recommended.
Patients with renal or hepatic insufficiency.

Tissugel reflector must be used with caution in patients with renal or hepatic ( See section 'Special warnings and precautions for use').
Method of administration.

zelfklevendverbandgaas The application to affected area.
for making the translucent membrane that geloppervlak protect, delete.

This is a medicine, no prolonged use without medical advice, keep away from children, read the leaflet carefully. Ask your doctor or pharmacist. In case of side effects, contact your doctor.

Contraindications:


Hypersensitivity to active substance or to any of the excipients, particularly for propylene glycol, methylparahydroxybenzoëzuur or propylparahydroxybenzoëzuur.
Individual confirmed hypersensitivity to aspirin or other non-steroidal anti-inflammatory drugs (see 'side effects'). Reflector should not be used Tissugel in patients taking aspirin or other non-steroidal anti-inflammatory agents was followed by an asthma attack, urticaria or acute rhinitis (because of the existence of cross-allergy).
Prolonged treatment (especially if several related gases used simultaneously) is contraindicated in patients with gastric or duodenal ulcer.

Special warnings and precautions for use:


Tissugel reflector should not be applied to open wounds (eg scratches, cuts). Reflector may Tissugel not come into contact with eyes and mucous membranes.
With prolonged use of reflector Tissugel is recommended that liver, kidney, and gastrointestinal tolerance and blood pressure to follow patients at risk (elderly or patients with liver - or kidney disease, arterial hypertension and gastro-intestinal records).

Pregnancy and lactation:


Pregnancy.
1 st and the 2 term:
reproduction studies in animals have demonstrated no fetal risk. However, there are no controlled studies in pregnant women. Because of the lack of experience Tissugel reflector may be used in those circumstances.
The 3 quarter: Given the possible risk of premature closure of the ductus arteriosus and uterine inertia during this period Tissugel reflector should not be prescribed.
Lactation.

Tissugel reflector may however be used when breastfeeding as the active ingredient only when dagdosissen from 150 mg orally, rectally or parenteral passes into breast milk, and then in such small quantities that no adverse effects on the infant to fear.

Side effects:


The following side effects may be observed reflector Tissugel:
Skin and subcutaneous tissue disorders.

In susceptible patients sometimes occurs pruritus, redness, burning and skin rash and rarely on photosensitization. As with all dermal substances used, any element of reflector Tissugel an allergic reaction.
Sensitizing.

patients who can not tolerate aspirin or certain additives are hypersensitivity reactions of skin and mucous membranes not excluded despite local use: eg asthma, angioedema, urticaria. Patients with asthma and chronic urticaria are particularly sensitive.
With prolonged use of reflector Tissugel or simultaneous use of multiple related impregnated gauze, following systemic side effects can not be excluded:
Blood and lymphatic system disorders:
very rare cases of serious blood disorders (no proven causal link).
Nervous Disorders:
feeling of vertigo, headache.
Very rare: fatigue, insomnia, irritability.
Vascular disorders
:-run against hypertension.
Gastrointestinal disorders:
epigastric pain, nausea and vomiting, diarrhea.
rarer: more pronounced erosions and occult blood loss, possibly ulcer and melena.
Hepatobiliary disorders
: transaminasenstijging.
Very rare: jaundice, hepatitis.
Skin and subcutaneous tissue disorders
: rare rash.
Kidney - and urinary disorders:
very rare nephrotic syndrome and renal failure.
General disorders:
general malaise, peripheral edema.
Hypersensitivity reactions:
very rarely bronchospasm and systemic, anaphylactic reactions.

Effects on ability to drive and use machines:


Under the current views reflector does not affect Tissugel the ability to drive or use machines.

Overdose:


If
unthinking use or accidental overdose (eg children) of reflector Tissugel would cause significant systemic side effects, the general measures that are recommended in cases of intoxication with non-steroidal anti-inflammatory drugs.

List of excipients:


Gelatin - Polyvinylpyrrolidone - D-sorbitol solution (70%) - Kaolin - Titanium Oxide - Propylene glycol - Methylparahydroxybenzoëzuur - Propylparahydroxybenzoëzuur - Dinatriumeetaat - Tartaric acid - Dihydroxyaluminiumaminoacetaat - Carboxy - natriumcarboxyvinyl polymerized (natriumpolyacrylaat) - 1,3-Butylene - Polysorbate 80 - Perfume (Dalin PH) - Purified water.

Interaction with other medicinal products and other forms of interaction:


To date, no interactions with other drugs described during treatment with reflector Tissugel. Reflector Tissugel not mix with other topical anti-inflammatory agent. There was no significant interaction if combined with non-steroidal anti-inflammatory drugs, administered by general way.
With prolonged use of reflector Tissugel or simultaneous use of multiple gases linked to interactions with drugs known to interfere they with non-steroidal anti-inflammatory drugs (such as lithium, digoxin, diuretics, anticoagulants, oral antidiabetics, methotrexate, cyclosporin, glucocorticoids, and quinolones), not be excluded.

Incompatibilities:


Not applicable.

 

Type of product
Medicine
No reviews

16 other products in the same category:

Product added to wishlist
Product added to compare.

We use cookies to provide you with the best possible service. By visiting our website you agree to the placing of cookies.